Brief: OSE Immunotherapeutics To Present At Summits In London And Boston
11/05/2022 17:29
May 11 (Reuters) - OSE Immunotherapeutics SA OSE.PA :
* OSE IMMUNOTHERAPEUTICS TO PRESENT AT 'IMMUNO-ONCOLOGY
SUMMIT
EUROPE' AND AT 'TUMOR MYELOID-DIRECTED THERAPIES SUMMIT' IN
LONDON AND BOSTON
* PRESENTATIONS TO FOCUS ON CLEC-1, NOVEL MYELOID IMMUNE
CHECKPOINT TARGET FOR CANCER IMMUNOTHERAPY
Source text for Eikon: ID:nBw29kLjLa
Further company coverage: OSE.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))
Recent news on Ose Immunotherapeutics SA
See all newsFactbox: Moderna-Merck melanoma vaccine leads race for first therapeutic cancer vaccine
Brief: OSE Immunotherapeutics SA Appoints Thomas Gidoin As Deputy CEO
Brief: Ose Immunotherapeutics Will Pause Development Of OSE‑230
Brief: OSE Immunotherapeutics Gets Second Positive IDMC Nod For Phase 3 Lung Cancer Trial
Brief: OSE Immunotherapeutics Announces Appointment Of Marc Le Bozec As Interim CEO